The transfer of drugs and other chemicals into human milk

Pediatrics

Volumn 108, Issue 3, 2001, Pages 776-789

  Ward, R M ^a   Bates, B A ^a   Benitz, W E ^a   Burchfield, D J ^a   Ring, J C ^a   Walls, R P ^a   Walson, P D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMPHETAMINE; CANNABIS; CLOMIPRAMINE; COCAINE; COPPER 64; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESIPRAMINE; DIAMORPHINE; DIAZEPAM; DOXORUBICIN; FLUVOXAMINE; GALLIUM 67; INDIUM 111; IODINE 123; IODINE 131; LORAZEPAM; METHOTREXATE; MIDAZOLAM; NICOTINE; PHENCYCLIDINE; PRAZEPAM; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SILICONE; TECHNETIUM 99M; UNINDEXED DRUG;

BREAST FEEDING; BREAST MILK; CELL METABOLISM; CHILD CARE; DRUG MILK LEVEL; HUMAN; LACTATION; MEDICAL SOCIETY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SMOKING;

EID: 0034877516     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.108.3.776     Document Type: Review

References (392)

1. The transfer of drugs and other chemicals into human breast milk
2. Transfer of drugs and other chemicals into human milk
3. Transfer of drugs and other chemicals into human milk
4. Alcohol and nicotine poisoning in nurslings
5. Determination of nicotine concentrations in human milk
6. Nicotine and cotinine concentrations in the milk of smoking mothers: Influence of cigarette consumption and diurnal variation
7. Nicotine and cotinine concentrations in serum and milk of nursing mothers
8. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers
9. Feeding and urine cotinine values in babies whose mothers smoke
10. Smoking and passive smoking during pregnancy and early infancy: Effects on birth weight, lactation period, and cotinine concentrations in mother's milk and infant's urine
11. Cigarette smoke exposure and development of infants throughout the first year of life: Influence of passive smoking and nursing on cotinine levels in breast milk and infant's urine
12. Milk production by mothers of premature infants: Influence of cigarette smoking
13. Maternal smoking during lactation: Relation to infant size at one year of age
14. Maternal smoking during lactation: Relation to growth during the first year of life in a Dutch birth cohort
15. Half lives of nicotine in milk of smoking mothers: Implications for nursing
16. Acute respiratory illness in Adelaide children: Breast feeding modifies the effect of passive smoking
17. Sclerodermalike esophageal disease in children breast-fed by mothers with silicone breast implants
18. Esophageal dysmotility in children breast-fed by mothers with silicone breast implants: Long-term follow-up and response to treatment
19. What is silicone?
20. Silicone breast implants and breast-feeding
21. Health outcomes in offspring of mothers with breast implants
22. Breast milk contamination and silicone implants: Preliminary results using silicon as a proxy measurement for silicone
23. Cyclophosphamide in human milk
24. Neutropenia from cyclophosphamide in breast milk
25. The presence of cyclosporine in body tissue and fluids during Pregnancy
26. Breast-feeding during treatment with cyclosporine
27. Doxorubicin and cisplatin excretion into human milk
28. Secretion of methotrexate into human milk
29. Amphetamine secretion in breast milk
30. Cocaine intoxication in a breast-fed infant
31. The effect of maternal narcotic addiction on the newborn infant: Review of literature and report of 22 cases
32. Presence of delta9-tetrahydrocannabinol in human milk
33. PCP in amniotic fluid and breast milk: Case report
34. Secretion of copper 64 into breast milk following intravenous injection in a human subject
35. Uptake of 67Ga in the lactating breast and its persistence in milk: Case report
36. Indium-111 radioactivity in breast milk
37. Radiation dosimetry from breast milk excretion of radioiodine and pertechnetate
38. Excretion of iodine-123-hippuran, technetium-99 m-red blood cells, and technetium-99 m-macroaggregated albumin into breast milk
39. Excretion of 125I in breast milk following administration of labelled fibrinogen
40. Secretion of radioiodine in digestive juices and milk in man
41. The amount and form of radioactivity in human milk after lung scanning, renography and placental localization by 131 I labelled tracers
42. Radioactive iodine uptake by thyroid of breast-fed infants after maternal blood-volume measurements
43. 131) to infants through human maternal milk
44. Iodine-131 in breast milk following therapy for thyroid carcinoma
45. The excretion of radiopharmaceuticals in human breast milk: Additional data and dosimetry
46. Secretion of radio-active sodium in human milk
47. Excretion of radioactivity in breast milk following 99Tcm-Sn polyphosphate
48. Radiation dose to breast-feeding
49. Duration of radioactivity in the milk of a nursing mother following 99 mTc administration
50. Human breast milk excretion of radionuclides following administration of radiopharmaceuticals
51. Radioactive excretion in human milk following administration of technetium Tc 99 m macroaggregated albumin
52. Excretion of technetium in human milk
53. Psychotropic drugs in pregnancy and lactation
54. Pharmacokinetics in lactating women: Prediction of alprazolam transfer into milk
55. Diazepam and breast-feeding
56. Diazepam and active metabolite in breast milk and their transfer to the neonate
57. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam
58. Clinical significance of methohexital, meperidine, and diazepam in breast milk
59. Quantification of naturally occurring benzodiazepine-like substances in human breast milk
60. Excretion of lorazepam into breast milk
61. Midazolam and nitrazepam in the maternity ward: Milk concentrations and clinical effects
62. Perphenazine in breast milk and serum
63. Concentrations of N-descyclopropylmethylprazepam in whole-blood, plasma, and milk after administration of prazepam to humans
64. Excretion of quazepam into human breast milk
65. Excretion of temazepam in breast milk
66. Amitriptyline in human breast milk and the nursing infant's serum
67. Tricyclics and breast feeding
68. Single case study. Amoxapine, a new antidepressant, appears in human milk
69. Excretion of bupropion in breast milk
70. Toxic neonatal effects following maternal clomipramine therapy
71. Excretion of imipramine and desipramine in human breast milk
72. Desipramine and 2-hydroxydesipramine in human breast milk and the nursery infant's serum
73. Serum and breast-milk concentrations of dothiepin
74. The excretion of dothiepin and its primary metabolites in breast milk
75. Excretion of doxepin and N-desmethyldoxepin in human milk
76. Fluoxetine/norfluoxetine concentrations in human milk
77. Possible association between fluoxetine hydrochloride and colic in an infant
78. Fluoxetine/norfluoxetine concentrations in human milk
79. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk
80. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair
81. Excretion of fluoxetine in human breast milk
82. The safety of fluoxetine during pregnancy and lactation
83. Fluoxetine in breast-milk and developmental outcome of breast-fed infants
84. Weight gain in infants breastfed by mothers who take fluoxetine
85. Excretion of fluvoxamine in breast milk
86. Serum nortriptyline levels in nursing mothers and their infants
87. Nortriptyline treatment of breast-feeding women
88. Paroxetine in human breast milk and nursing infants
89. Sertraline and breastfeeding
90. Sertraline and desmethylsertraline in human breast milk and nursing infants
91. Excretion of trazodone in breast milk
92. Effects of chlorpromazine on pituitary function
93. Chlorpromazine levels in plasma and milk of nursing mothers
94. Excretion of iohexol and metrizoate in human breast milk
95. Determination of chlorpromazine in human breast milk and serum by high-performance liquid chromatography
96. Presence of chlorprothixene and its metabolites in breast milk
97. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk
98. Haloperidol excretion in human milk
99. Haloperidol secreted in breast milk
100. Measurement of haloperidol in human breast milk by high-performance liquid chromatography
101. Neuroleptic drugs in breast milk: A study of pharmacokinetics and of possible adverse effects in breast-fed infants
102. Side effects in the neonate from psychotropic agents excreted through breast-feeding
103. Use of amiodarone during pregnancy
104. Excretion of chloramphenicol in human milk
105. Chloramphenicol (Chloromycetin) in the treatment of tsutsugamushi disease (scrub typhus)
106. Excretion of clofazimine in human milk in leprosy patients
107. Lamotrigine in pregnancy and lactation: A case report
108. Metoclopramide as a lactogogue
109. Metoclopramide and breast feeding: Transfer into milk and the newborn
110. Metronidazole in breast milk
111. Blood and milk concentrations of metronidazole in mothers and infants
112. Tinidazole milk excretion and pharmacokinetics in lactating women
113. To nurse when receiving acebutolol: Is it dangerous for the neonate?
114. Diarrhea due to 5-aminosalicylic acid in breast milk
115. 5-Aminosalicylic acid its metabolite in breast milk during lactation
116. Negligible excretion of 5-aminosalicylic acid in breast milk
117. Accumulation of atenolol and metoprolol in human breast milk
118. Toxic effects of atenolol consumed during breast feeding
119. Levels of the beta-blockers atenolol and propanolol in the breast milk of women treated for hypertension in pregnancy
120. Atenolol and metoprolol. A comparison of their excretion into human breast milk
121. Atenolol in human plasma and breast milk
122. Effects of bromocriptine mesylate on the composition of the mammary secretion in non-breastfeeding women
123. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine
124. A 16-day-old breast-fed infant with metabolic acidosis caused by salicylate
125. Salicylate pharmacokinetics in the human neonate
126. Salicylate excretion in breast milk
127. Drowsiness due to clemastine transmitted in breast milk
128. Untersuchungen uber den ubergang des aktiven agens des mutterkorns in die milch stillender mutter
129. Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment
130. Toxic effects of lithium in newborn infants: A commentary
131. Lithium carbonate and breastfeeding
132. Breast-feeding and anticoagulant therapy
133. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers
134. Primidone and phenobarbital during lactation period in epileptic women: Total and free drug serum levels in the nursed infants and their effects on neonatal behavior
135. Methaemoglobinaemia in newborn probably due to phenytoin excreted in human milk
136. Drugs transmitted through breast milk. II. Barbiturates
137. Infantile spasms on weaning from breast milk containing anticonvulsants
138. Bloody diarrhea - A possible complication of sulfasalazine transferred through human breast milk
139. Disposition of acetaminophen in milk, saliva, and plasma of lactating women
140. Excretion of paracetamol in human breast milk
141. Analgesic drugs in breast milk and plasma
142. Acetazolamide excretion into human breast milk
143. Acitretin excretion into human breast milk
144. Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure
145. Acyclovir in human breast milk
146. Pseudo-Cushing syndrome caused by alcohol in breast milk
147. Effect of different doses of ethanol on the milk-ejecting reflex in lactating women
148. Ethanol and acetaldehyde in the milk and peripheral blood of lactating women after ethanol administration
149. Maternal alcohol use during breast-feeding and infant mental and motor development at one year
150. Allopurinol and oxypurinol in human breast milk
151. Passage of cephalosporins and amoxicillin into the breast milk
152. Concentration of Pentostam in human breast milk
153. Excretion of drugs in human milk: Review
154. Excretion of azpropazone in human breast milk
155. Aztreonam in human serum and breast milk
156. The effect of thiamin and riboflavin supplementation on the level of those vitamins in human breast milk and urine
157. Vitamin B6 nutriture during pregnancy lactation. I. Vitamin B6 intake, levels of the vitamin in biological fluids, condition of the infant at birth
158. Influence of vitamin B6 intake on the content of the vitamin in human milk
159. Dangers of vitamin B6 in nursing mothers
160. Vitamin B12 in human colostrum and milk. Quantitation of the vitamin and its binder and the uptake of bound vitamin B12 by intestinal bacteria
161. Concentrations of baclofen in serum and breast milk from a lactating woman
162. Suppressing lactaton with oral diuretics
163. Effect of dicumarol on the nursing infant
164. Drugs transmitted through breast milk. III. Bromides
165. Human perinatal distribution of butorphanol
166. Excretion of the methylxanthines in human milk
167. Caffeine secretion into breast milk
168. Lack of pharmacological active saliva levels of caffeine in breast-fed infants
169. Disposition of dietary caffeine in milk, saliva, and plasma of lactating women
170. Caffeine in human milk and in serum of breast-fed infants
171. Effect of maternal caffeine consumption on heart rate and sleep time of breast-fed infants
172. Captopril in human blood and breast milk
173. Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics
174. Carbamazepine: Placental transport, tissue concentrations in foetus and newborn, and level in milk
175. Transfer of carbetocin into human breast milk
176. Antithyroid drugs: To breast-feed or not to breast-feed
177. Antithyroid treatment of maternal hyperthyroidism during lactation
178. Drugs transmitted through breast milk. I. Laxatives
179. Transfer of cefazolin into human milk
180. Transmammary passage of cefoxitin: Additional results
181. Excretion of cefprozil into human breast milk
182. Ceftazidime levels in human breast milk
183. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum
184. Dichloralphenazone and breast milk
185. A study of the conditions that require the removal of the child from the breast
186. Da concentracao e eliminacao da cloroquina atraves da circulacao placentaria e do leite materno, de pacientes sob regime do sal loroquinado
187. Excretion of chloroquine and desethylchloroquine in human milk
188. Excretion of chloroquine, dapsone and pyrimethamine in human milk
189. Excretion of chlorothiazide in human breast milk
190. Hydrochlorothiazide disposition in a mother and her breast-fed infant
191. Placental transfer of chlorthalidone and its elimination in maternal milk
192. Cimetidine excretion into breast milk
193. Active transport of cimetidine into human milk
194. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant
195. Pharmacokinetics of three newer quinolones in pregnant and lactating women
196. Secretion of the gastrokinetic agent cisapride in human milk
197. Clindamycin in human breast milk
198. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy
199. Codeine and the breastfed neonate
200. Breast-feeding during colchicine therapy for familial Mediterranean fever
201. Colchicine in breast milk of patients with familial Mediterranean fever
202. Colchicine is excreted at high concentrations in human breast milk
203. Long-term follow-up of children breast-fed by mothers using oral contraceptives
204. Transfer of contraceptive steroids to human milk
205. Breast-feeding and contraception
206. The effect of oral contraceptives on concentration of various components of human milk
207. Effect of oral contraceptives on lactation
208. Oral-contraceptive feminization of a normal male infant: Report of a case
209. Effect of oral contraceptives on lactation
210. Effects of oestrogen and progestagen on the composition of human milk
211. Should women taking antituberculosis drugs breast-feed?
212. Relationship between the vitamin D content of maternal milk and the vitamin D status of nursing women and breast-fed infants
213. Maternal-infant vitamin D relationships during breast-feeding
214. High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2
215. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers
216. Sulphone levels in breast milk of mothers on sulphone therapy
217. Drug toxicity from breast milk?
218. Intravenous urography during lactation
219. Digoxin excretion in human breast milk
220. Excretion of drugs in human milk
221. Excretion of diltiazem in human milk
222. Excretion of dipyrone metabolites in human breast milk
223. Excretion of disopyramide in human breast milk
224. Disopyramide and breast feeding
225. Domperidone and lactation
226. Dyphylline elimination kinetics in lactating women: Blood to milk transfer
227. The excretion of enalapril and enalaprilat in human breast milk
228. Transfer of antibiotics into maternal milk
229. Transfer of estradiol to human milk
230. Ethosuximide pharmacokinetics in a pregnant patient and her newborn
231. Concentration of fentanyl in colostrum after an analgesic dose
232. Terfenadine pharmacokinetics in breast milk in lactating women
233. Flecainide excretion in human breast milk
234. Coadministration of flecainide acetate and sotalol during pregnancy: Lack of teratogenic effects, passage across the placenta, and excretion in human breast milk
235. Penetration of fleroxaein into breast milk and pharmacokineties in lactating women
236. Fluconazole concentrations in breast milk
237. The breast milk excretion of flufenamic acid
238. Excretion of fluorescein into breast milk
239. Aspects of folate metabolism in lactating women studied after ingestion of 14C-methylfolate
240. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk
241. Gentamicin excretion and uptake from breast milk by nursing infants
242. Gold secretion in maternal milk
243. Letter: Metabolism of gold during lactation
244. Suggested errata
245. Excretion of gold into human breast milk
246. Use of sodium aurothiomalate during lactation
247. Trace concentrations of halothane in human breast milk
248. Transplacental passage and breast milk concentrations of hydralazine
249. Hydroxychloroquine in human breast milk
250. Excretion of hydroxychloroquine in human milk
251. A study to evaluate the passage of ibuprofen into breast-milk
252. Excretion of ibuprofen into breast milk
253. Convulsions in a breast-fed infant after maternal indomethacin
254. Convulsions in a breast-fed infant after maternal indomethacin
255. Excretion of indomethacin in breast milk
256. Iodine in mother's milk
257. Cholecystography during lactation
258. Isoniazid and acetylisoniazid disposition in human milk, saliva and plasma
259. Transfer of interferon alfa into human breast milk
260. Ivermectin levels in human breast milk
261. Ivermectin levels in human breast milk
262. Influence on the prothrombin time of breast-fed newborn babies of one single dose of vitamin K1 or synkavit given to the mother within 2 hours after birth
263. Vitamin K-1 content of maternal milk: Influence of the stage of lactation, lipid composition, and vitamin K-1 supplements given to the mother
264. Disposition of maternal ketoconazole in breast milk
265. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing
266. Transfer of labetalol into amniotic fluid and breast milk in lactating women
267. Concentration of beta-blocking drugs in human milk
268. Fertility regulation in nursing women: VII. Influence of Norplant levonorgestrel implants upon lactation and infant growth
269. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant by nursing mothers
270. ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk
271. The effects of a progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breastfeeding
272. Thyroid hormones in human milk and their influence on thyroid function of breast-fed babies
273. Lidocaine excretion in breast milk
274. Secretion of the antidiarrhoeal agent loperamide oxide in breast milk
275. Excretion of loratadine in human breast milk
276. Breast milk magnesium and calcium concentrations following magnesium sulfate treatment
277. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community
278. The breast milk excretion of mefenamic acid
279. Exogenous opioids in human breast milk and acute neonatal neurobehavior: A preliminary study
280. Methadone assays in pregnant women and progeny
281. Drug addiction in pregnancy and the neonate
282. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme
283. Methadone levels in breast milk
284. Methadone levels in human milk
285. Methimazole pharmacology in man: Studies using or newly developed radioimmunoassay for methimazole
286. Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants
287. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants
288. Drugs can be dangerous during pregnancy and lactations
289. Excretion of metrizamide in milk
290. Mexiletine use in pregnancy and lactation
291. Mexiletine in human blood and breast milk
292. Minoxidil in breast milk
293. The elimination of morphine and quinine in human milk
294. Morphine excretion in breast milk and resultant exposure of a nursing infant
295. Prenatal and breast milk morphine exposure following maternal intrathecal morphine treatment
296. Human breast milk concentration of moxalactam
297. Nadolol in human serum and breast milk
298. Haemolytic anaemia due to nalidixic acid
299. Naproxen excretion in milk and its uptake by the infant
300. Nefopam excretion in human milk
301. Nifedipine transfer into human milk
302. The excretion of orally ingested nitrofurantoin in human milk
303. Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrel
304. Radioactivity in the milk of subjects receiving radioactive 19-norsteroids
305. Excretion of noscapine in human breast milk
306. Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk
307. Excretion of oxprenolol and timolol in breast milk
308. Verabreichung von irgapyrin bei schwangeren und wochnerinnen
309. Diphenylhydantoin: Placental transport, fetal localization, neonatal metabolism, and possible teratogenic effects
310. Piroxicam in human breast milk
311. Secretion of prednisolone into breast milk
312. Pharmacokinetics of prednisolone transfer to breast milk
313. Entry of prednisone into human milk
314. Procainamide excretion in human milk
315. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring
316. Excretion of propoxyphene and norpropoxyphene in breast milk
317. Propranolol therapy during pregnancy and lactation
318. Letter: Excretion of propranolol in human breast milk
319. Propranolol in human plasma and breast milk
320. Propylthiouracil in human milk: Revision of a dogma
321. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers
322. Pyridostigmine in human breast milk
323. Transfer of pyrimethamine in human milk
324. The use of quinidine sulfate throughout pregnancy
325. Identification and quantification of drugs and drug metabolites in human breast milk using gas chromatography mass spectrometry computer methods
326. Quantitative excretion of Senokot in human breast milk
327. Excretion of sotalol in breast milk
328. Spironolactone: Relationship between concentrations of dethioacetylated metabolite in human serum milk
329. Sulbactam kinetics and excretion into breast milk in postpartum women
330. Sulphasalazine treatment during breast feeding
331. Disposition of salicylazosulfapyridine (Azulfidine) and metabolites in human breast milk
332. Sulfisoxazole secretion into human milk
333. Distribution and excretion of sumatriptan in human milk
334. Suprofen concentrations in human breast milk
335. Transfer of terbutaline into breast milk
336. Tetracycline in breast milk Br Med J
337. Further observations on the use of tetracycline hydrochloride in prophylaxis and treatment of obstetric infections
338. Theophylline secretion into breast milk
339. Concentrations of thiopentone in mature breast milk and colostrum following an induction dose
340. Thiouracil: Its absorption, distribution, and excretion
341. Ticarcillin serum and tissue concentrations in gynecology and obstetrics
342. Tolbutamide orinase in human breast milk
343. Tolmetin in breast milk
344. Etude du passage de la trimethoprime dans le lait maternel
345. The passage of trimethoprim/sulphamethoxazole into breast milk and its significance. Proceedings of the 8th International Congress of Chemotherapy, Athens
346. Sodium valproate and pregnancy
347. Valproic acid in breast milk: How much is really there?
348. Verapamil and norverapamil in plasma and breast milk during breast feeding
349. May mothers given warfarin breast-feed their infants?
350. Zolpidem excretion in breast milk
351. Aflatoxin detected in human breast milk by immunoassay
352. Aflatoxins in breast milk, neonatal cord blood and sera of pregnant women
353. Aflatoxin M1 in human breast milk from The Gambia, west Africa, quantified by combined monoclonal antibody immunoaffinity chromatography HPLC
354. Plasma, erythrocyte human milk levels of free amino acids in lactating women administered aspartame or lactose
355. Neonatal bromism secondary to maternal exposure in a photographic laboratory
356. Cadmium concentrations in milk and blood of smoking mothers
357. Chlordane residues in human milk
358. Breast milk distribution of theobromine from chocolate
359. Occupationally derived chemicals in breast milk
360. Organo-chlorine pesticide residues in human fat and human milk
361. DDT in human milk
362. Insecticides in human breast milk
363. Some observations concerning the ratio of the intake of organochlorine insecticides through food and amounts excreted in the milk of breast-feeding mothers
364. National study of chlorinated hydrocarbon insecticide residues in human milk, USA. I. Geographic distribution of dieldrin, heptachlor, heptachlor epoxide, chlordane, oxychlordane, and mirex
365. DDT concentrations in human milk
366. Transfer of DDT used in malaria control to infants via breast milk
367. Organochlorine pesticides in Western Australian nursing mothers
368. Favism in a nursing infant
369. An investigation of fluoride concentration in the milk of nursing mothers
370. Effect of maternal fluorine intake on breast milk fluorine content
371. Le passage dans le lait des aliments ou medicaments absorbes par denourrices
372. Transfer of hexachlorobenzene (HCB) from mother to newborn baby through placenta and milk
373. Hexachlorophene concentrations in human milk
374. Lead in milk and infant blood: A dose-response model
375. Lead and cadmium in breast milk. Higher levels in urban vs rural mothers during the first 3 months of lactation
376. Lead in human blood and milk from nursing women living near a smelter in Mexico City
377. Lead in breast milk
378. Mercury toxicity in the pregnant woman, fetus, and newborn infant. A review
379. Studies of infants postnatally exposed to methylmercury
380. Mercury in human maternal and cord blood, placenta, and milk
381. Methyl methacrylate levels in the breast milk of a patient after total hip arthroplasty
382. Monosodium glutamate: Effect on plasma and breast milk amino acid levels in lactating women
383. Pollutants in breast milk: PCBs and cola-colored babies
384. Pollutants in breast milk
385. Polychlorinated biphenyl contamination of nursing mothers' milk in Michigan
386. Breast-milk monitoring to measure Michigan's contamination with polybrominated biphenyls
387. Testing for polychlorinated biphenyls in human milk
388. Obstructive jaundice due to a chlorinated hydrocarbon in breast milk
389. A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia neurologic abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian